Analysis of performance characteristics of five cell cycle-related immunohistochemical markers and human papillomavirus genotyping in the diagnosis of cervical squamous cell carcinoma precursor lesions

Analytical and Quantitative Cytology and Histology

Volumn 34, Issue 1, 2012, Pages 49-55

  Conesa Zamora, Pablo ^a   Trujillo Santos, Javier ^a   Orantes Casado, Francisco Javier ^a   Ortiz Reina, Sebastián ^a   Torres Moreno, Daniel ^a   Pérez Guillermo, Miguel ^a  

^a Santa Maria del Rosell University Hospital   (Spain)

Author keywords

Cyclin D1; Human papillomavirus; Immunohistochemical markers; Ki67; Logistic regression; p16, ProEx C; Squamous intraepithelial lesion

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROEX C; PROTEIN P16; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CELL CYCLE; CELL CYCLE REGULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SQUAMOUS EPITHELIUM; SQUAMOUS INTRAEPITHELIAL LESION; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84861008585     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wells M, Östor AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, Goodman AK, Sankaranarayanan R, Hanselaar AG, Albores Saavedra J: Tumors of the uterine cervix: Epithelial tumors. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Edited by FA Tavassoli, P Devilee. Lyon, IARC Press, 2003, pp 262-279
2. DeMay RM (editor): The Pap smear. In The Art and Science of Cytopathology. Chicago, American Society of Clinical Pathologist Press, 1996, pp 61-205
3. Agoff SN, Dean T, Nixon BK, Ingalls-Severn K, Rinker L, Grieco VS: The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: Effect on Hybrid Capture II human papillomavirus testing and clinical follow-up. Am J Clin Pathol 2002;118:727-732
4. Shi J, Liu H, Wilkerson M, Huang Y, Meschter S, Dupree W, Schuerch C, Lin F: Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol 2007;38:1335-1344
5. Chen Y, Miller C, Mosher R, Zhao X, Deeds J, Morrissey M, Bryant B, Yang D, Meyer R, Cronin F, Gostout BS, Smith- McCune K, Schlegel R: Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003; 63:1927-1935
6. Santin AD, Zhan F, Bignotti E, Siegel ER, Cané S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S: Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: Identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005;331:269-291
7. Badr RE, Walts AE, Chung F, Bose S: BD ProEx C: A sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008;32:899-906
8. Conesa-Zamora P, Doménech-Peris A, Ortiz-Reina S, Orantes-Casado FJ, Acosta-Ortega J, García-Solano J, Pérez- Guillermo M: Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix. J Clin Pathol 2009;62:159-162
9. Pinto AP, Schlecht NF, Woo TY, Crum CP, Cibas ES: Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol 2008;21:1067-1074
10. Conesa-Zamora P, Doménech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahuquillo-Frías L, Acosta-Ortega J, García- Solano J, Pérez-Guillermo M: Effect of human papillomavirus on cell cycle related proteins p16, Ki67, cyclin D1, p53 and ProEx C in precursor lesions of cervical carcinoma: A tissue microarray study. Am J Clin Pathol 2009;132:378-390
11. Qiao X, Bhuiya TA, Spitzer M: Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis 2005;9:100-107
12. Sánchez-Hernández M, Conesa-Zamora P, García-Solano J, Corbalán-Vélez R, Martínez-Barba E, Pérez-Guillermo M: Expression profiles of ProEx C and Ki67 in squamous cell carcinoma in situ of the skin and their relationship with human papillomavirus genotypes. J Cutan Pathol 2010;37: 730-736
13. Hosmer DW, Lemeshow S: Logistic regression. In Applied Logistic Regression. Edited by NAC Cressie, NI Fisher, IM Johnstone, JB Kadane, DW Scott, BW Silverman, AFM Smith, JL Teugels, V Barnett, RA Bradley, JS Hunter, DG Kendall. New York, John Wiley and Sons, 2000, pp 91-143
14. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172
15. Ordi J, Garcia S, del Pino M, Landolfi S, Alonso I, Quintó L, Torné A: p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol 2009; 28:90-97
16. Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R; European CINtec Histology Study Group: Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010;133:395-406
17. Schneider V: Tissue microarrays for testing molecular biomarkers of cervical intraepithelial neoplasia: Feasibility study. Acta Cytol 2006;50:123-128
18. Feng W, Xiao J, Zhang Z, Rosen DG, Brown RE, Liu J, Duan X: Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol 2007;20:961-966
19. Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006;110:525-541
20. Park J, Sun D, Genest DR, Trivijitsilp P, Suh I, Crum CP: Coexistence of low and high grade squamous intraepithelial lesions of the cervix: Morphologic progression or multiple papillomaviruses? Gynecol Oncol 1998;70:386-391
21. Baak JPA, Stoler MH, Bean SM, Anderson MC, Robboy SJ: Cervical precancer, including functional biomarkers and colposcopy. In Pathology of the Female Reproductive Tract. Edited by SL Robboy, GL Mutter, J Prat, RC Bentley, P Russell, MC Anderson. New York, Churchill Livingstone, 2009, pp 189-226
22. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
23. Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A: Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2000;6:3600-3606
24. Pregibon D: Logistic regression diagnostics. Ann Stat 1981; 9:705-724
25. Schmidt D, Bergeron C, Denton KJ, Ridder R; for the European CINtec Cytology Study Group: p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: Results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 2011;119:158-166